Schiltigheim, France

Marina Kapfer

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 3.1

ph-index = 1


Location History:

  • Castelnau d'Estretefonds, FR (2013)
  • Schiltigheim, FR (2013 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Marina Kapfer

Introduction

Marina Kapfer, based in Schiltigheim, France, is a notable inventor with a portfolio of seven patents to her name. Her work primarily focuses on advancements in biotechnology, particularly regarding avian cell systems and their applications in therapeutic developments.

Latest Patents

Kapfer's most recent patents include groundbreaking innovations such as the "Avian telomerase reverse transcriptase" and "Immortalized avian cell lines comprising E1A nucleic acid sequences." The first patent deals with novel recombinant telomerase reverse transcriptases along with nucleic acid molecules coding for them. It explores how cells containing these nucleic acids can be utilized for producing substances of interest. The second patent focuses on immortalized avian cells, emphasizing their utility in producing viruses and recombinant viral vectors. These vectors have significant implications for therapeutic and prophylactic applications, particularly in treating both animals and humans.

Career Highlights

Marina is currently associated with Transgene S.A., a company renowned for its innovations in gene therapy and immunotherapy. Her contributions have played a crucial role in pushing the boundaries of what is possible in biotechnology. Her expertise in the field has not only advanced her career but has also significantly impacted the research community.

Collaborations

In her endeavors, Kapfer collaborates with talented professionals such as Nathalie Silvestre and Philippe Erbs. These partnerships reflect her commitment to fostering teamwork and leveraging collective expertise to drive innovation in her field.

Conclusion

Marina Kapfer exemplifies the spirit of innovation in biotechnology. With her array of patents and ongoing work at Transgene S.A., she continues to pave the way for future advancements that promise to benefit both medical science and society at large. Through her inventions, she demonstrates the profound impact that dedicated inventors can have on technology and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…